Grand Pharmaceutical Group Limited (HK:0512) has released an update.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Grand Pharmaceutical Group Limited has renewed its exclusive distribution agreements with Sirtex Medical for 2024, allowing its subsidiaries, Beijing Purevalley and Chengdu Purevalley, to continue reselling Sirtex’s products in China. The agreements, initially established in 2023, have been extended to enhance the company’s presence in the Chinese market. This move represents ongoing collaboration between the two firms and aligns with connected transaction regulations.
For further insights into HK:0512 stock, check out TipRanks’ Stock Analysis page.